Abstract 3966: Targeting S100A10, a SOX9 binding protein, for the treatment of triple negative breast cancer
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-3966
Abstract: Background: Triple-negative breast cancers (TNBCs) are the most aggressive breast cancers and have a very poor prognosis. Since TNBCs lack the expression of the estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and… read more here.
Keywords: s100a10; sox9; growth; breast ... See more keywords